Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methyldopa hydrate (MK-351 hydrate) is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system, decreases production of dopamine, norepinephrine, and epinephrine, and exhibits NO-dependent sedative activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 9,500 | |||
1 g | 在庫あり | ¥ 11,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Methyldopa hydrate (MK-351 hydrate) is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system, decreases production of dopamine, norepinephrine, and epinephrine, and exhibits NO-dependent sedative activity. |
別名 | Alpha-Methyldopa Sesquihydrate, L-(-)-α-Methyldopa hydrate, MK-351 hydrate, Methyldopa Sesquihydrate |
分子量 | 238.24 |
分子式 | C10H13NO4·3/2H2O |
CAS No. | 41372-08-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33.33 mg/mL (139.90 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methyldopa hydrate 41372-08-1 GPCR/G Protein Neuroscience Dopamine Receptor Adrenergic Receptor L-α-Methyldopa Hydrate MK351 Hydrate Methyldopa MK351 metabolized prodrug MK 351 Methyldopa Hydrate Alpha-Methyldopa Sesquihydrate α-Methyldopa Sesquihydrate hyperglycemic L-(-)-α-Methyldopa hydrate L-alpha-Methyldopa Hydrate L-a-Methyldopa Hydrate Beta Receptor MK-351 hydrate Methyldopa Sesquihydrate antihyoertensive response MK-351 MK 351 Hydrate Inhibitor a-Methyldopa Sesquihydrate MK-351 Hydrate inhibit inhibitor